Global Microelectronic Medical Implants Market Size to Reach $57.12 Billion by 2025
April 23, 2018 | PRNewswireEstimated reading time: 1 minute
The global microelectronic medical implants market size is anticipated to reach $57.12 billion by 2025, according to a new report by Grand View Research, Inc., registering a 9.8% CAGR during the forecast period. Increasing prevalence of cardiac disorders, epilepsy, and Parkinson's disease, growing regulatory approvals for new devices and equipment, rising geriatric population, and introduction of new products are key factors driving market growth.
Regulatory authorities such as U.S. FDA have approved several new products and devices to be used by end users, most of which are equipped with new and innovative technologies that cater to varied consumer demands. These technologies also increase the ease of use of these products. For instance, in July 2017, Cochlear Ltd. introduced to the market a cochlear implant sound processor for iPhone. The U.S. FDA approved this innovation in June 2017.
Increasing prevalence of diseases such as epilepsy, cardiac disorders, and Parkinson's disease have upped the sales of microelectronic electronic implants such as defibrillators, pacemakers, and neurostimulators.As per WHO, approximately 50 million people have epilepsy, globally, making it one of the most common neurological disorders.
The condition can be treated using neurostimulators that prevent seizures.
Further key findings from the study suggest:
- By product, the pacemakers and defibrillators segment accounted for the largest share in 2016 owing to increasing prevalence of cardiovascular diseases and rising geriatric population
- RF technology accounted for the largest share in 2016 as it is employed in wireless implants and helps researchers and clinicians monitor patient health, capture physiological data, and study normal and abnormal functioning of the body
- North America commanded the largest share in the microelectronic medical implants market in 2016 and is expected to maintain its position over the forecast period. This is owing to favorable government policies, increasing FDA approvals for various medical devices in U.S., and high incidence of cardiac diseases
- Key market players include Zimmer Biomet Holdings, Inc.; Cochlear Ltd.; Medtronic plc; Abbott Laboratories; Zoll Medical; Boston Scientific Corporation; LivaNova PLC; Biotronik; Schiller; and Koninklijke Philips N.V.
Suggested Items
In-Memory Computing: Revolutionizing Data Processing for the Modern Era
04/21/2025 | Persistence Market ResearchIn a world where milliseconds matter, traditional computing architectures often struggle to keep up with the massive influx of real-time data.
Cicor Acquires Significant Business Activities of Éolane
04/21/2025 | CicorCicor Group announces that its offer for the acquisition of significant business activities of the French Éolane Group has been accepted by the Paris Commercial Court. This strategic transaction marks a milestone in the execution of Cicor's pan-European growth strategy and further strengthens its market leadership in the aerospace and defence sector.
China Smartphone Market Grew 3.3% in 1Q25, Outperforming Global Growth Ahead of US-China Trade Tensions
04/17/2025 | IDCAccording to preliminary data from the International Data Corporation (IDC) Worldwide Quarterly Mobile Phone Tracker, China's smartphone market shipped 71.6 million units in 1Q25, a 3.3% year-on-year (YoY) increase.
IPC Strengthens Electronics Industry Awareness with Appointment of Carrie Sessine as Global Communications Vice President
04/16/2025 | IPCIPC, the global electronics association, announces the strategic appointment of Carrie Sessine as vice president of global communications. This newly created executive position underscores the association’s commitment to championing the electronics industry's critical contributions to global innovation and economic growth.
QD-OLED to Account for 73% of OLED Monitor Shipments in 2025, Driven by Advancing Technology and New Products
04/16/2025 | TrendForceTrendForce’s latest investigations reveal that ongoing advancements in OLED displays are propelling the growth of QD-OLED monitor shipments. QD-OLED’s share of OLED monitor shipments is expected to rise from 68% in 2024 to 73% in 2025, highlighting its strong competitiveness in the high-end monitor market.